You are here

Structural & Congenital Heart Disease


Next-day discharge after minimalist transcatheter aortic valve replacement (TAVR) was safe for patients who didn’t experience perioperative complications and was linked to better one-year outcomes versus patients discharged later, according to a single-center study published in JACC: Cardiovascular Interventions.

The American Heart Association (AHA) and American College of Cardiology (ACC) rolled out new guidelines for managing valvular heart disease (VHD) in 2017, marking the second overhaul of VHD recommendations in three years—a move attributable to “extensive new data” that have shaped the way clinicians treat valve disease.

A larger valve option and more appropriate valve sizing using preprocedural imaging may eliminate the previously reported survival disparity between men and women undergoing transcatheter aortic valve replacement (TAVR), a new study in JACC: Cardiovascular Interventions suggests.

Procedures to replace or repair patients’ tricuspid valves (TVs) remain rare but have increased in recent years, according to a study in the Journal of the American College of Cardiology. But despite this increased volume, in-hospital mortality has remained steady at 8.8 percent.

The Centera transcatheter heart valve (THV) shows promise in addressing the “Achilles’ heel” of transcatheter aortic valve replacement (TAVR), according to Luis Nombela-Franco, MD, PhD, who wrote an editorial about the device’s pivotal study published in the Journal of the American College of Cardiology.


Recent Headlines

Newborns with congenital heart disease at increased risk for neurodevelopmental disabilities

Infants born with congenital heart disease (CHD) could be at increased risk for neurodevelopmental disabilities even before undergoing initial open-heart surgery, a new study published in NeuroImage: Clinical states.

Long-term survival rates after Ross procedure positive 25 years later

Adults who underwent the Ross procedure saw overwhelmingly “excellent” long-term outcomes 25 years later, according to a study published in the Journal of the American College of Cardiology.

Percutaneous mitral valve repair safe, effective in frail patients

Patients classified as frail who undergo percutaneous mitral valve repair (PMVR) demonstrate greater short-term improvement in quality of life than their nonfrail counterparts and similar improvements in six-minute walking distance and functional status, a new study found.

Study finds hope in penicillin treatment for children with latent rheumatic heart disease

Penicillin prophylaxis could have a positive, regressive effect on young patients diagnosed with latent rheumatic heart disease (RHD), one study of Ugandan children has found.

Research finds longitudinal durability of TAVR is 'excellent'

Longitudinal durability of transcatheter aortic valve replacements (TAVR) is “excellent,” according to a recent study published in JAMA Cardiology, and is similar to surgical bioprostheses used to treat severe aortic stenosis.

Cardiac patients supported by ECMO as infants report good health, but lower quality of life years later

Adults who struggled with heart disease as infants and had to be supported by extracorporeal membrane oxygenation reported positive health outcomes but lower quality of life 18 years later, according to a study published in Pediatric Critical Care Medicine.

Is 70% good enough?

Not exactly. A recent study, the largest of its kind that tracked more than 1,000 children, found a 70 percent success rate using balloon aortic valvuloplasty (BAV) to treat isolated congenital aortic stenosis (AS).

Women significantly more likely to die during AVR surgeries

Women are far more susceptible to dangerous risk factors and mortality following aortic valve replacement (AVR) procedures, according to a study newly published in the Journal of the American Heart Association.

20-year study examines predictors of heart disease, PAD

Although coronary heart disease (CHD) and peripheral arterial disease (PAD) share a handful of characteristics and risk factors, they affect different vascular territories and vary in pathogenesis, a study of more than two decades has found.

Patients with schizophrenia face shorter lives, greater cardiovascular risk

Despite an overall decline in mortality of individuals who suffer from schizophrenia, patients living with the mental illness are still experiencing shorter lives and have a higher rate of cardiovascular disease (CVD) than the general population, according to a new study published in the Canadian Medical Association Journal.